WALLEYE CAPITAL LLC – Crinetics Pharmaceuticals, Inc. Transaction History
WALLEYE CAPITAL LLC portfolio value:
$4.91M
portfolio value
WALLEYE CAPITAL LLC quarter portfolio value change:
+5.31%
quarter
Crinetics Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +62.25% | 95.92K shares | 2.03M | $19.64 | 250.01K |
| Q2 2022 | share | Decrease | -16.05% | -29.45K shares | -1.15M | $18.65 | 154.09K |
| Q1 2022 | share | Increase | +109.50% | 95.93K shares | 1.54M | $21.95 | 183.54K |
| Q4 2021 | share | Increase | 0.00% | 87.60K shares | 2.48M | $28.03 | 87.60K |
| Q1 2021 | share | Decrease | -100.00% | -12.1K shares | -171K | $15.28 | 0 |
| Q4 2020 | share | Increase | 0.00% | 12.1K shares | 171K | $14.11 | 12.1K |